Reaction Kinetic Models of Antibiotic Heteroresistance

Area of Science:

• Pharmacodynamics
• Mathematical Biology
• Microbiology

Background:

• Bacterial heteroresistance, characterized by co-existing subpopulations with differing antibiotic susceptibilities, can impede bacterial clearance.
• Current mathematical models often simplify drug-target interactions, limiting the explicit modeling of multi-step reaction pathways crucial for bacterial killing.
• Existing approaches struggle to capture complex mechanisms underlying delayed bacterial clearance in heteroresistant infections.

Purpose of the Study:

• To develop pharmacodynamic models incorporating multi-step reaction pathways for antibiotic action.
• To model bacterial heteroresistance and identify molecular factors contributing to delayed bacterial killing.
• To evaluate the utility of Gillespie algorithms for simulating antibiotic effects via multi-step reactions.

Main Methods:

• Utilized Gillespie algorithms, a stochastic simulation method for chemical kinetics, to model antibiotic action through multi-step reactions.
• Developed novel pharmacodynamic models to explicitly represent reaction pathways leading to bacterial death.
• Investigated the impact of molecular heterogeneities on bacterial killing dynamics.

Main Results:

• Demonstrated the applicability of Gillespie simulations for modeling antibiotic action involving multi-step reaction kinetics.
• Identified that slight, normally distributed variances in reaction rates within the bacterial death pathway can induce heteroresistance.
• Showcased that these molecular variations can lead to delayed bacterial killing, a hallmark of heteroresistance.

Conclusions:

• Pharmacodynamic models incorporating multi-step reactions and Gillespie simulations offer valuable insights into antibiotic action.
• Minor molecular variations in bacterial pathways can be a primary driver of heteroresistance and delayed bacterial clearance.
• The findings suggest that a slowly declining bacterial population due to heteroresistance is a common scenario that must be considered when determining antibiotic treatment duration.